Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to ...

The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its telehealth offering, Business Insider has learned. 23andMe has been testing the waters for a buyer ...

23andMe's stock plummeted after a 2023 data breach exposed millions of customer accounts. The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its ...

23andMe has been exploring a possible sale of its telehealth business, Business Insider has learned. The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million.

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Me still merchandises its ancestry, health analysis, and the Total Health annual package on a scale from $99 to $999 annually. Lemonaid entered the hot GLP-1 prescribing and support business in 2024, ...

I wanna start by saying I'm not anti-AI. Far from it, actually. I think AI is amazing, and nothing will come between my ChatGPT subscription and me. So, if you're an AI superfan ...

23andMe has been steadily expanding beyond its ... Reimagining What's Possibl Artificial intelligence (AI) has long promised to transform the life sciences, but today, we stand at a critical ...

Here’s how it works. In a very short amount of time AI video has gone from short, 2-3 second clips barely identifiable as video to tools like Google Veo 2 capable of generating minutes of high ...